Sarcoma (Jan 1999)
Evaluation of Dose-Intense Ifosfamide, with and Without Edatrexate, in Adults with Sarcoma
Abstract
Purpose. To define the maximally tolerated dose (MTD) of ifosfamide when given with G-CSF on an every other week schedule, and to define the MTD of edatrexate that can be given every two weeks with an intense schedule of ifosfamide.